YVONNE HUANG: Open Payments
NPI 1063049252 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,973 in 120 payments from 18 companies in 2025. Trend: 2023 $2,070 · 2024 $2,142 · 2025 $2,973
Food & beverage: $2,968Education: $5
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $372 |
| Incyte Corporation | 12 | $362 |
| Galderma Laboratories, L.P. | 14 | $327 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $251 |
| ABBVIE INC. | 10 | $239 |
| GENZYME CORPORATION | 8 | $225 |
| Janssen Biotech, Inc. | 9 | $194 |
| Amgen Inc. | 5 | $189 |
| Regeneron Healthcare Solutions, Inc. | 7 | $154 |
| Arcutis Biotherapeutics, Inc. | 7 | $150 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, OPZELURA, RINVOQ, ILUMYA, TREMFYA, OTEZLA.
Industry payments across NY — which companies pay providers there.
